live
attenu
recombin
measl
vaccin
viru
mv
edmonstonzagreb
ez
strain
evalu
viral
vector
express
ectodomain
fusion
protein
respiratori
syncyti
viru
rsv
f
glycoprotein
epsteinbarr
viru
ebv
candid
vaccin
prophylaxi
rsv
ebv
glycoprotein
gene
insert
st
rd
posit
measl
viru
genom
recombin
virus
gener
insert
foreign
gene
rd
posit
minim
impact
viral
replic
vitro
rsv
f
ebv
protein
secret
infect
cell
cotton
rat
ezrsv
f
ezebv
induc
mvand
insertspecif
antibodi
respons
addit
vaccin
also
induc
insert
specif
interferon
gamma
ifn
secret
cell
respons
ezrsv
f
protect
cotton
rat
pulmonari
replic
rsv
challeng
infect
rhesu
macaqu
although
ezrsv
f
ezebv
induc
mv
specif
neutral
antibodi
respons
rsv
f
specif
antibodi
respons
detect
thu
immunogen
foreign
antigen
deliv
measl
vaccin
viru
depend
natur
insert
anim
model
use
vaccin
evalu
live
attenu
virus
develop
use
help
protect
human
variou
infecti
diseas
live
attenu
vaccin
virus
simul
natur
infect
highli
immunogen
effect
induc
humor
cellular
immun
respons
demonstr
safeti
effect
infecti
diseas
differ
live
attenu
vaccin
virus
explor
vector
express
heterolog
antigen
measl
vaccin
mv
strain
long
histori
demonstr
safeti
human
induc
long
last
immun
includ
antibodi
cell
respons
aerosol
administr
measl
vaccin
also
develop
shown
induc
similar
better
immunogen
compar
convent
subcutan
intramuscular
vaccin
aerosol
administr
rout
may
offer
advantag
help
protect
individu
mucos
pathogen
develop
revers
genet
neg
strand
rna
virus
includ
measl
viru
made
possibl
explor
util
neg
strand
rna
virus
deliv
foreign
antigen
measl
vaccin
viru
explor
sever
laboratori
express
foreign
antigen
spike
nucleocapsid
protein
sar
coronaviru
hiv
hpv
hepat
b
surfac
antigen
vector
mv
induc
robust
antibodi
cell
respons
insert
antigen
address
correspond
author
medimmun
north
bernardo
ave
mountain
view
ca
usa
tel
fax
email
jinh
medimmunecom
author
contribut
work
equal
mv
make
attract
option
vaccin
measl
well
infecti
agent
although
studi
show
mv
could
boost
measl
viru
immun
respons
school
age
children
previous
receiv
measl
vaccin
preexist
immun
measl
viru
may
reduc
immunogen
vector
measl
vaccin
thu
util
mv
vector
measl
seroposit
popul
remain
determin
sever
studi
perform
earli
develop
countri
reveal
high
seroconvers
rate
achiev
ez
measl
vaccin
despit
presenc
high
titer
matern
measl
viru
antibodi
therefor
ez
strain
might
immunogen
popul
histori
measl
vaccin
preexist
mv
immun
studi
explor
use
ez
vaccin
strain
deliv
viral
antigen
prevent
rsv
ebv
associ
diseas
rsv
caus
sever
lower
respiratori
tract
ill
infant
elderli
bronchiol
rsv
infect
infant
associ
recurr
wheez
asthma
childhood
vaccin
avail
prevent
morbid
mortal
rsv
infect
surfac
fusion
f
protein
rsv
major
antigen
protein
induc
neutral
antibodi
cytotox
lymphocyt
protect
subsequ
rsv
challeng
mice
cotton
rat
high
level
f
neutral
antibodi
suffici
protect
lower
respiratori
tract
infect
use
prophylact
purpos
infant
ebv
gamma
herp
viru
caus
infecti
mononucleosi
adolesc
addit
ebv
associ
certain
malign
includ
burkitt
lymphoma
posttransplant
lymphoprolif
diseas
lymphoma
nasopharyng
carcinoma
prophylact
ebv
vaccin
avail
surfac
glycoprotein
bind
human
receptor
b
cell
mediat
viral
entri
identifi
protect
antigen
adjuv
ebv
protein
shown
efficaci
random
phase
ii
studi
prevent
infecti
mononucleosi
report
construct
infecti
measl
viru
revers
genet
system
insert
f
protein
respiratori
syncyti
viru
ebv
mv
viru
separ
transcript
unit
vector
virus
evalu
cotton
rat
rhesu
macaqu
immunogen
virus
cell
rsv
strain
obtain
atcc
manassa
ez
vaccin
strain
serum
institut
india
pune
india
vero
cell
maintain
dulbecco
modifi
eagl
medium
invitrogen
carlsbad
ca
supplement
fetal
bovin
serum
fb
lglutamin
penicillinstreptomycin
co
antigenom
cdna
synthes
menlo
park
ca
base
sequenc
live
attenu
measl
viru
edmonstonzagreb
strain
ncbi
dna
access
number
rna
polymeras
promot
sequenc
ad
end
antigenom
cdna
hepat
delta
viru
ribozym
rna
polymeras
termin
sequenc
ad
end
antigenom
cdna
sequenc
nucleotid
sca
mlu
modifi
facilit
cdna
clone
three
amino
acid
residu
posit
k
r
n
k
r
differ
ez
vaccin
strain
correct
sitedirect
mutagenesi
mv
antigenom
cdna
clone
vector
denot
pez
fig
support
plasmid
encod
measl
n
p
l
gene
clone
pcite
plasmid
control
promot
previous
describ
design
pn
pp
pl
respect
construct
measl
vaccin
vector
encod
ecto
domain
rsv
f
ebv
protein
express
virusinfect
vero
cell
rsv
f
ectodomain
ebv
ectodomain
insert
st
rd
transcript
unit
measl
zagreb
strain
genom
insert
perform
noncod
region
proxim
mv
n
gene
p
gene
pez
control
addit
measl
transcript
unit
contain
gene
stop
ge
gene
start
gs
sequenc
rsv
f
gene
aa
insert
ecorv
site
use
blunt
ligat
ebv
full
length
aa
ebv
truncat
aa
rsv
f
gene
insert
ecorv
afei
site
b
vero
cell
infect
moi
measl
virus
encod
solubl
rsv
f
solubl
ebv
tr
h
western
blot
use
detect
presenc
measl
viru
nucleoprotein
infect
vero
cell
lysat
rsv
f
protein
ebv
protein
supernat
black
arrowhead
indic
predict
molecular
mass
protein
rel
intens
mv
n
protein
band
express
intens
band
rel
rez
control
construct
measl
viru
vector
antigenom
cdna
ectodomain
rsv
f
ebv
ectodomain
insert
noncod
region
proxim
n
gene
junction
p
gene
pez
fig
insert
gene
contain
measl
viru
transcript
unit
consist
sequenc
n
gene
stop
gen
p
gene
start
gsp
insert
rsv
f
gene
promot
proxim
locat
pucsnabisacii
pucss
subclon
contain
promot
mv
sequenc
silent
mutat
nt
knockout
ecorv
enzym
site
gener
gene
cassett
contain
ectodomain
rsvf
aa
follow
gen
gsp
sequenc
insert
ecorv
site
nt
genom
dna
multipl
nucleotid
rule
six
snab
isac
ii
fragment
swipe
back
pez
antigenom
cdna
fig
result
cdna
denot
insert
rsv
f
gene
ebv
gene
pez
p
gene
pucsaciinari
pucsn
subclon
contain
mv
sequenc
nt
nt
construct
gene
cassett
contain
gene
end
ge
n
gene
start
gs
p
ectodomain
rsvf
aa
full
length
aa
truncat
aa
ectodomain
spei
site
nt
sac
ii
nar
fragment
swipe
back
pez
antigenom
cdna
fig
result
cdna
denot
respect
gener
recombin
measl
viru
vector
measl
virus
rescu
recombin
virus
mv
antigenom
cdna
perform
previous
describ
briefli
cell
infect
multipl
infect
moi
hour
prior
transfect
dna
mixtur
pez
pn
pp
pl
cotransfect
infect
cell
use
lipofectamin
invitrogen
carlsbad
ca
cultur
medium
replac
dmem
contain
fb
overnight
incub
c
transfect
cell
incub
addit
day
cultur
supernat
use
infect
fresh
vero
cell
amplifi
rescu
viru
rescu
virus
plaqu
purifi
twice
vero
cell
virus
rescu
pez
design
rez
respect
evalu
recombin
measl
virus
replic
cell
cultur
replic
kinet
rez
virus
compar
vero
cell
vero
cell
sixwel
plate
infect
viru
moi
triplic
hour
adsorpt
room
temperatur
cell
wash
three
time
phosphatebuff
salin
pb
incub
ml
complet
dmem
c
co
aliquot
cultur
supernat
collect
daili
well
day
store
c
viru
titrat
viral
titer
determin
plaqu
assay
vero
cell
previous
describ
replic
kinet
perform
twice
triplic
supernat
sampl
titer
duplic
western
blot
vero
cell
infect
moi
rez
hour
cultur
supernat
cell
harvest
separ
cell
scrape
pellet
sec
rpm
microfug
tube
lyse
lysi
buffer
trishcl
mm
nacl
triton
volvol
proteas
inhibitor
cocktail
ph
sigma
st
loui
mo
min
ice
result
cell
lysat
clear
centrifug
rpm
min
protein
cultur
supernat
cell
lysat
separ
electrophoresi
transfer
onto
pvdf
membran
viral
protein
detect
antimeasl
nucleoprotein
clone
santa
cruz
biotechnolog
polyclon
rabbit
ebv
monoclon
antibodi
rsv
f
protein
palivizumab
medimmun
gaithersburg
md
antibodi
intens
band
quantifi
imagequ
softwar
ge
healthcar
piscataway
nj
rel
intens
determin
compar
pixel
intens
band
rel
rez
control
cotton
rat
studi
specificpathogenfre
cotton
rat
purchas
harlan
indianapoli
anim
studi
protocol
approv
medimmun
institut
anim
care
use
committe
anim
anesthet
isofluran
inhal
vaccin
intramuscularli
im
pfu
rez
inoculum
volum
control
group
inocul
intramuscularli
im
pb
pfu
uvinactiv
intrans
pfu
rsv
strain
anim
boost
dose
virus
week
later
anim
observ
clinic
sign
daili
bled
interv
measur
antibodi
respons
twentyeight
day
second
immun
cotton
rat
measl
viru
vector
rsv
vaccin
group
challeng
pfu
rsv
strain
lung
harvest
day
postchalleng
viral
titer
determin
plaqu
assay
rhesu
macaqu
studi
adult
rhesu
macaqu
age
yearold
use
immunogen
studi
valley
biosystem
west
sacramento
ca
experiment
procedur
approv
institut
anim
use
care
committe
medimmun
valley
biosystem
measl
vaccin
immun
histori
rhesu
macaqu
confirm
neutral
assay
prior
studi
total
rhesu
macaqu
measl
viru
seroposit
use
studi
half
anim
measl
viru
seroposit
receiv
two
dose
intramuscularli
use
pfuinocul
half
receiv
two
dose
dose
intramuscularli
inocul
perform
week
interv
blood
drawn
anim
everi
day
assess
immun
respons
anim
anesthet
ketamin
intramuscularli
procedur
clinic
symptom
monitor
veterinarian
durat
studi
ebv
rsv
f
proteinspecif
elisa
assay
ebv
rsv
fspecif
enzymelink
immunosorb
assay
elisa
perform
determin
level
f
proteinspecif
antibodi
briefli
ng
purifi
recombin
solubl
ebv
rsv
f
protein
express
mammalian
cell
adsorb
onto
immulon
plate
overnight
pb
plate
block
bsa
pb
serial
dilut
anim
sera
bsa
ad
plate
incub
hour
room
temperatur
wash
hrpconjug
anticotton
rat
igg
immunolog
consult
laboratori
newberg
antirhesu
macaqu
igg
rockland
immunochem
boyertown
pa
ad
incub
hour
final
plate
develop
tetramethylbenzidin
peroxidas
substrat
kpl
rockford
il
stop
hcl
absorb
sampl
read
nm
titer
sampl
calcul
determin
dilut
absorb
reach
time
read
serum
control
lower
limit
detect
log
log
ebv
elisa
rsv
f
elisa
respect
neutral
assay
measl
viru
specif
neutral
antibodi
determin
describ
previous
plate
use
vero
cell
neutral
antibodi
titer
defin
highest
dilut
inhibit
cpe
rsv
specif
neutral
antibodi
determin
plaqu
reduct
neutral
assay
describ
previous
lower
limit
detect
log
log
mv
microneutr
rsv
plaqu
reduct
assay
respect
ebv
specif
neutral
antibodi
titer
determin
method
describ
sashihara
et
al
elispot
assay
elispot
assay
perform
spleen
vaccin
control
cotton
rat
day
second
dose
peripher
blood
mononucleocyt
cell
pbmc
rhesu
monkey
day
second
dose
splenocyt
isol
previous
describ
splenocyt
count
use
vicel
beckman
coulter
brea
ca
gamma
interferon
ifn
interleukin
cell
quantifi
enzymelink
immunospot
elispot
assay
use
r
duoset
elisa
system
cotton
rat
ifnand
antibodi
r
system
minneapoli
mn
previous
describ
use
ebv
rsv
f
protein
stimul
spot
scan
count
immunospot
spot
analyz
cellular
technolog
cleveland
oh
number
ifnor
secret
cell
express
number
cell
per
cell
statist
graphpad
prism
softwar
use
analyz
data
graphpad
softwar
inc
san
diego
ca
data
express
mean
standard
error
data
also
analyz
mannwhitney
rank
sum
test
compar
data
distribut
two
experiment
group
titer
comparison
virus
replic
kinet
experi
perform
use
kruskalw
test
assum
nonparametr
distribut
revers
genet
system
measl
edmonstonzagreb
ez
vaccin
viru
establish
transfect
mv
antigenom
plasmid
pez
togeth
pp
pn
pl
infect
cell
recov
infecti
ez
viru
gener
rez
express
rsv
f
ebv
f
ectodomain
rsv
ebv
clone
mv
antigenom
cdna
fig
f
clone
two
posit
viral
genom
one
proxim
n
gene
st
posit
p
gene
rd
posit
ebv
ectodomain
ntermin
half
amino
acid
encod
receptor
bind
site
also
clone
ez
genom
st
rd
posit
recombin
ez
rsv
f
ebv
ebv
insert
st
rd
posit
gener
howev
virus
insert
st
posit
replic
poorli
vitro
evalu
rescu
recombin
virus
express
rsv
f
ebv
design
f
st
posit
f
rd
posit
rd
posit
respect
confirm
recombin
measl
virus
express
desir
antigen
express
insert
infect
vero
cell
examin
western
blot
analysi
addit
mv
n
protein
detect
infect
cell
lysat
fig
rsv
f
ebv
detect
cultur
supernat
infect
cell
fig
indic
product
secret
form
rsv
f
protein
viru
infect
cell
observ
lower
mv
n
express
vero
cell
infect
compar
virus
may
attribut
insert
rsv
f
proxim
mv
n
gene
move
mv
n
gene
nd
posit
genom
reduc
mrna
transcript
level
rel
express
rsv
f
mv
n
howev
shown
higher
compar
consist
observ
gene
proxim
end
genom
transcrib
abundantli
downstream
rsv
f
produc
per
virion
viral
replic
effici
recombin
virus
assess
growth
kinet
vero
cell
recombin
ez
rez
ez
vaccin
virus
grew
peak
titer
log
pfuml
day
fig
rez
either
rsvf
fig
fig
insert
compar
growth
kinet
slightli
lower
log
lower
rez
peak
titer
virus
statist
differ
faster
growth
kinet
reach
peak
titer
day
instead
day
therefor
insert
rsv
f
ebv
genom
ez
significantli
reduc
viral
growth
vitro
cotton
rat
previous
demonstr
semipermiss
measl
viru
infect
best
avail
small
anim
model
mv
infect
addit
cotton
rat
suscept
rsv
infect
use
evalu
rsv
vaccin
antirsv
antibodi
investig
prophylact
applic
abil
rez
vector
vaccin
induc
humor
respons
measl
viru
rsv
f
ebv
protein
assess
cotton
rat
cotton
rat
immun
fig
growth
kinet
measl
vector
encod
solubl
rsv
f
solubl
ebv
similar
recombin
measl
construct
vero
cell
infect
moi
measl
vector
cell
incub
c
day
cell
supernat
sampl
daili
viru
titer
use
standard
plaqu
assay
denot
statist
signific
differ
titer
versu
rez
ez
use
kruskalw
test
fig
rsv
fspecif
ebv
splenocyt
induc
spleen
cotton
rat
immun
im
measl
vector
cotton
rat
vaccin
day
measl
vector
splenocyt
harvest
day
second
measl
vector
vaccin
total
x
cell
stimul
either
rsv
f
protein
c
ebv
protein
b
vitro
h
number
ifnspotform
cell
b
spotform
cell
c
quantifi
elispot
assay
spot
count
autom
count
devic
express
number
spot
per
cell
group
compar
use
mannwhitney
rank
sum
test
symbol
repres
individu
anim
tabl
control
anim
vaccin
uvinactiv
rsv
viru
detect
mv
ab
titer
data
shown
rsvspecif
antibodi
respons
measur
rsv
fspecif
elisa
microneutr
assay
induc
rsv
fspecif
igg
antibodi
vaccin
cotton
rat
log
post
dose
log
post
dose
rsv
fspecif
igg
antibodi
titer
similar
vaccin
group
rsv
neutral
antibodi
titer
also
measur
rsv
strain
first
dose
induc
rsv
neutral
ab
titer
boost
second
dose
tabl
statist
differ
antibodi
respons
vaccin
anim
intranas
infect
dose
rsv
strain
log
data
shown
anim
vaccin
uvinactiv
detect
rsv
antibodi
data
shown
indic
viru
immunogen
depend
live
viru
infect
ebvspecif
antibodi
respons
measur
ebv
elisa
assay
ebv
specif
elisa
ab
respons
detect
one
dose
administr
nd
dose
titer
reach
log
vaccin
anim
respect
tabl
induc
significantli
higher
ebv
igg
titer
ebv
specif
neutral
antibodi
could
detect
ebv
neutral
assay
cell
mediat
immun
respons
import
viral
clearanc
may
play
import
role
vaccin
mediat
protect
immun
respons
rsv
fspecif
ebv
cell
respons
splenocyt
examin
ifnand
elispot
day
post
nd
dose
frequenc
rsv
fspecif
ifnsecret
cell
statist
higher
vaccin
group
averag
splenocyt
compar
vaccin
averag
splenocyt
rsv
anim
averag
splenocyt
fig
rsv
fspecif
secret
cell
low
averag
splenocyt
group
surprisingli
rsvspecif
secret
cell
detect
rsv
anim
fig
thu
rsv
induc
respons
base
higher
ifnto
secret
cell
ratio
frequenc
ebv
ifnand
secret
cell
averag
spot
splenocyt
ifnand
respect
vaccin
group
averag
spot
splenocyt
ifnand
respect
statist
differ
statist
higher
pb
control
group
group
fig
anim
model
avail
assess
ebv
vaccin
induc
protect
immun
respons
cotton
rat
best
avail
small
anim
model
evalu
rsv
vaccin
induc
protect
wt
rsv
challeng
infect
assess
immun
respons
induc
could
provid
protect
rsv
challeng
vaccin
cotton
rat
challeng
rsv
intranas
viru
titer
lung
measur
similar
rsv
infect
anim
offer
complet
protect
rsv
challeng
viral
titer
lung
least
log
lower
control
anim
contrast
cotton
rat
vaccin
pfu
uvinactiv
viral
titer
similar
pb
control
group
indic
viral
replic
necessari
induct
protect
immun
respons
fig
rhesu
macaqu
fulli
permiss
measl
viru
infect
use
evalu
measl
vaccin
measl
viru
pathogenesi
studi
abil
rez
vector
rsv
f
ebv
induc
measl
viru
specif
f
specif
immun
respons
examin
permiss
anim
model
sinc
demonstr
better
immunogen
cotton
rat
evalu
measl
viru
seroposit
mv
rhesu
macaqu
prior
measl
vaccin
measl
viru
seroneg
mv
rhesu
macaqu
abnorm
clinic
sign
observ
serum
chemistri
within
normal
rang
monkey
throughout
studi
data
shown
vaccin
monkey
induc
similar
level
mv
neutral
antibodi
mvand
mv
monkey
second
dose
vaccin
increas
mv
neutral
ab
titer
group
tabl
ab
titer
differ
group
statist
signific
fig
reduct
titer
rsv
lung
cotton
rat
vaccin
measlesvector
rsv
f
challeng
cotton
rat
immun
pfu
day
cotton
rat
challeng
pfu
rsv
day
lung
harvest
day
rsv
titer
determin
lung
homogen
standard
plaqu
assay
experiment
group
repres
individu
anim
except
uvinactiv
group
antibodi
respons
insert
gene
howev
rel
low
inocul
anim
rsv
fspecif
igg
titer
higher
prevaccin
level
titer
detect
limit
f
specif
igg
ab
titer
log
log
mv
mvgroup
dose
respect
second
dose
three
anim
mv
group
increas
rsv
fspecif
igg
ab
titer
none
anim
mvgroup
increas
ab
respons
fig
two
dose
vaccin
rsv
neutral
ab
titer
group
low
mv
mvgroup
seven
anim
detect
level
rsv
neutral
ab
rsv
nt
ab
titer
statist
differ
two
group
log
mv
versu
log
mvgroup
tabl
ab
respons
ebv
vaccin
monkey
detect
time
point
similar
antibodi
respons
ifnsecret
cell
pbmc
measl
viral
antigen
significantli
higher
respons
either
rsv
f
ebv
fig
pbmc
stimul
measl
viral
antigen
rsv
f
ebv
secret
thu
compar
cotton
rat
studi
rez
vector
virus
poorli
immunogen
primat
model
revers
genet
develop
gener
recombin
measl
viru
vector
vaccin
encod
foreign
antigen
base
edmonstonschwarz
aikc
vaccin
strain
revers
genet
system
describ
studi
base
ez
vaccin
strain
use
predominantli
outsid
us
ez
strain
might
immunogen
popul
prior
measl
vaccin
immun
ectodomain
rsv
f
ebv
glycoprotein
instead
full
length
protein
engin
express
ez
avoid
incorpor
foreign
surfac
glycoprotein
onto
measl
viru
envelop
express
heterolog
membran
protein
measl
viru
surfac
may
alter
bind
measl
natur
receptor
thu
chang
tissu
tropism
measl
viru
show
rsv
f
ebv
express
effici
vitro
howev
rez
vector
vaccin
induc
insert
specif
respons
cotton
rat
poor
respons
rhesu
macaqu
although
cotton
rat
rhesu
macaqu
previous
shown
permiss
measl
viru
infect
variou
degre
titer
prevaccin
anim
limit
detect
assay
one
import
determin
induc
robust
immun
respons
vivo
amount
express
antigen
level
antigen
present
evalu
effect
gene
insert
locat
antigen
express
level
transcript
nonseg
neg
strand
rna
virus
obligatorili
sequenti
gene
locat
proxim
promot
produc
abundantli
one
distal
promot
inde
rsv
f
introduc
proxim
n
gene
produc
time
secret
rsv
f
protein
insert
p
junction
data
shown
comparison
insert
ebv
posit
ez
significantli
affect
viru
replic
insert
ebv
gene
p
gene
less
effect
viru
growth
similar
shown
hepat
b
surfac
antigen
hbsag
gene
insert
posit
affect
immunogen
ez
vector
vaccin
cotton
rat
rez
encod
rsv
f
ectodomain
induc
antibodi
respons
measl
rsv
f
induc
mv
specif
antibodi
respons
compar
rez
rsv
specif
ab
respons
compar
induc
intranas
rsv
infect
cotton
rat
also
induc
cell
mediat
respons
measur
ifnelispot
assay
surprisingli
inferior
abil
induc
rsv
neutral
antibodi
rsv
fspecif
ifnsecret
cell
respons
suggest
may
attenu
vivo
immun
respons
depend
viral
infect
natur
insert
rez
vector
ebv
induc
lower
specif
igg
ab
respons
undetect
neutral
antibodi
respons
cotton
rat
cotton
rat
immun
mv
express
rsv
f
also
challeng
wt
rsv
challeng
number
ifnsecret
cell
higher
secret
cell
consist
respons
data
shown
rsv
enhanc
diseas
associ
firsv
vaccin
chimer
parainfluenza
viru
vector
rsv
f
caus
enhanc
diseas
hamster
proven
safe
phase
clinic
trial
seroneg
children
recent
report
anoth
group
shown
measl
viru
vector
rsv
f
caus
unusu
patholog
cotton
rat
rsv
challeng
thu
likelihood
mv
vector
f
caus
enhanc
diseas
low
sinc
cotton
rat
partial
permiss
mv
mv
vector
vaccin
evalu
rhesu
macaqu
rhesu
macaqu
fulli
permiss
measl
viru
infect
infect
monkey
develop
symptom
similar
experienc
human
skin
rash
fever
conjunct
monkey
model
use
neurovirul
test
mv
vaccin
addit
sinc
rhesu
macaqu
could
infect
human
measl
viru
breed
coloni
commonli
vaccin
mv
allow
us
examin
effect
prior
vaccin
vector
measl
mimic
target
popul
either
matern
antibodi
measl
vaccin
histori
rez
rez
express
induc
good
level
antibodi
respons
pbmc
measl
viru
irrespect
serostatu
mv
antibodi
respons
slightli
lower
magnitud
observ
cotton
rat
dose
per
kg
use
rhesu
time
lower
cotton
rat
antibodi
respons
f
insert
much
lower
rhesu
macaqu
previou
report
show
two
dose
mvhiv
tcid
time
higher
dose
studi
induc
robust
ab
respons
toward
hiv
monkey
howev
three
dose
tcid
dose
mv
vector
hbv
surfac
antigen
induc
low
respons
monkey
thu
low
humor
respons
vector
insert
rhesu
macaqu
may
due
lower
dose
use
studi
measl
vaccin
viru
shown
bind
signal
lymphocyt
activ
molecul
slam
also
known
activ
immun
cell
ubiquit
express
human
cell
thought
viru
infect
respiratori
tract
slam
dendrit
cell
cotton
rat
although
human
homolog
report
measl
viru
could
replic
lung
anim
intranas
infect
evalu
differ
rout
administr
intranas
intramuscular
mv
vector
rsv
f
cotton
rat
found
inocul
rout
offer
protect
rsv
challeng
immun
data
shown
rhesu
macaqu
possess
receptor
homolog
suscept
measl
viru
infect
develop
diseas
similar
human
differ
receptor
two
anim
speci
may
abl
explain
insert
insert
ez
strain
attenu
virus
reduc
immunogen
viru
rhesu
macaqu
cotton
rat
also
examin
replic
ez
vector
rsv
f
ebv
vivo
use
real
time
qrtpcr
sinc
differenti
growth
kinet
recombin
measl
viru
may
explain
differ
antibodi
respons
howev
abl
detect
measl
genom
pbmc
isol
whole
blood
hour
post
vaccin
may
attribut
low
copi
measl
viru
circul
blood
time
point
use
measur
measl
kinet
vivo
optim
conjunct
examin
replic
ez
vector
pbmc
rhesu
macaqu
ex
vivo
determin
insert
foreign
gene
affect
replic
virus
pbmc
phaactiv
pbmc
cell
infect
rmv
moi
growth
kinet
determin
day
peak
titer
recombin
virus
contain
rsv
f
ebv
log
lower
rez
data
shown
indic
vector
vaccin
could
infect
rhesu
cell
also
investig
genet
stabil
insert
serial
passag
recombin
virus
vero
cell
time
find
loss
insert
gene
express
report
previous
neg
strand
rna
virus
includ
newcastl
diseas
viru
ndv
vesicular
stomat
viru
sendai
viru
parainfluenza
virus
evalu
vector
deliv
foreign
antigen
shown
elicit
humor
cellular
respons
nonhuman
primat
confer
protect
viru
challeng
case
vector
vaccin
normal
deliv
nonhuman
primat
either
intranas
intratrach
inocul
rout
found
intranas
intramuscular
vaccin
ez
induc
similar
antibodi
respons
cotton
rat
possibl
intranas
immun
might
immunogen
intramuscular
vaccin
monkey
base
studi
mv
vector
probabl
suitabl
deliveri
ebv
antigen
immunogen
adjuv
protein
vaccin
demonstr
young
adult
adjvant
might
right
approach
ebv
vaccin
develop
amount
deliv
mv
like
suffici
induc
specif
immun
respons
f
protein
rsv
deliv
mv
immunogen
ebv
howev
addit
evalu
immunogen
mvrsv
f
must
conduc
proceed
test
vaccin
human
